Another advertisement for donepezil [1] (multiple letters)

Journal of the American Geriatrics Society

Volumn 52, Issue 5, 2004, Pages 843-

  Finucane, Thomas E ^a   Royall, Donald R ^b   Karlawish, Jason H T ^c   Geldmacher, David S ^d   Provenzano, George ^e   McRae, Thomas ^f   Ieni, John R ^g  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e BATTELLE MEMORIAL INSTITUTE   (United States)

^f PFIZER INC   (United States)

^g EISAI INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; LACTOSE; PLACEBO; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ALZHEIMER DISEASE; CAREGIVER; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; DRUG UTILIZATION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INSTITUTIONALIZATION; LETTER; METHODOLOGY; NURSING HOME; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; SURVIVAL RATE; ADVERTIZING; NOTE; TIME;

ADVERTISING; ALZHEIMER DISEASE; CAREGIVERS; CHOLINESTERASE INHIBITORS; HUMANS; INDANS; INSTITUTIONALIZATION; NOOTROPIC AGENTS; NURSING HOMES; PATIENT COMPLIANCE; PIPERIDINES; TIME FACTORS;

EID: 2342529108     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2004.52230_1.x     Document Type: Letter

References (0)